## Abstract The importance of designating criteria for diagnosing dementia lies in its implications for clinical treatment, research, caregiving, and decisionβmaking. Dementia diagnosis in Huntington's disease (HD) is often based on criteria developed for Alzheimer's disease requiring memory loss.
Functional decline in Huntington's disease
β Scribed by Dr. Andrew Feigin; Karl Kieburtz; Kathy Bordwell; Peter Como; Kimberly Steinberg; Jenny Sotack; Carol Zimmerman; Charlyne Hickey; Constance Orme; Ira Shoulson
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 312 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
We prospectively evaluated 129 patients with manifest Huntington's disease (HD) to determine the rate of illness progression and the clinical features that correlate with functional decline. A single examiner evaluated each patient using the HD Functional Capacity Scale. Standardized motor performance was also assessed in 94 of the patients (73%) using the HD Rating Scale. Total Functional Capacity declined at a rate of 0.63 Β± 0.75 U per year. As functional capacity worsened, chorea lessened, and dystonia intensified. There was no correlation between rate of functional decline and age at onset of HD, body weight, gender of affected parent, or history of neuroleptic use.
π SIMILAR VOLUMES
## Abstract Voluntary motor impairment is a functionally important aspect of Huntington's disease (HD). Therefore, quantitative assessment of disturbed voluntary movement might be important in followβup. We investigated the relation between quantitatively assessed daytime motor activity and symptom
Huntington's disease (HD) is a late-onset degenerative disorder of the central nervous system, caused by a dominantly inherited mutation in a gene on chromosome 4p. The identification of the trinucleotide repeat mutation responsible for this disorder has been an important step towards understanding
## Abstract The authors report a patient with Huntington's disease (HD) presenting with severe chorea. The motor scale of the unified HD rating scale (UHDRSβI) revealed 81 points. Motor function clearly improved with zotepine, until she reached an UHDRSβI of 34 points on day 7 of treatment. The pat